Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergoogle.com
Google Alert - relay therapeutics
Get the latest updates from Google Alert - relay therapeutics directly as they happen.
Follow now 146 followers
Latest posts
Last updated about 5 hours ago
Bridging tumour classification and treatment - The Lancet Oncology
about 22 hours ago
... Therapeutics, and Relay Therapeutics. VS reports speaker honoraria from Medscape and...
Fibroblast Growth Factors (FGFs) Market Growth Driven - openPR.com
1 day ago
... Pharmaceuticals, Inc., Relay Therapeutics, Abbisko Therapeutics Co, Ltd, BridgeBio Pharma, Inc...
Relay Therapeutics, Inc. (RLAY) Stock Analysis: A Biotech Bet With A 318% Potential Upside
5 days ago
Relay Therapeutics, Inc. (NASDAQ: RLAY) stands as a compelling story in the...
JPMorgan Begins Coverage on nCino (NCNO) stock, Gives Neutral - Yahoo Finance
6 days ago
... BofA Reiterates a Buy Rating on Relay Therapeutics (RLAY), Sets a...
Exchange Traded Concepts LLC Acquires 28,127 Shares of Autolus Therapeutics PLC ...
7 days ago
Relay Therapeutics, Inc. Shares Bought by Exchange Traded Concepts LLC.
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Bought by Exchange Traded Concepts LLC
7 days ago
You might be interested in: Relay Therapeutics, Inc. Shares Bought by ...
BofA Reiterates a Buy Rating on Relay Therapeutics (RLAY), Sets a $17 PT
7 days ago
Relay Therapeutics, Inc. (NASDAQ:RLAY) is a clinical-stage precision medicine company that uses...
Jefferies Maintains a Buy on Taysha Gene Therapies (TSHA) With an $8 PT
7 days ago
Relay Therapeutics, Inc. (NASDAQ:RLAY) is one of the 13 Best Long-Term...
Cholangiocarcinoma Clinical Trials Appears Robust With 55+ Key
8 days ago
Ltd., QED Therapeutics, Hutchison MediPharma, TriSalus Life Sciences, Relay Therapeutics, Eli Lilly...
With Public Funding Under Pressure, Biotech Innovators Are Picking Up the Slack in Oncology
11 days ago
(NASDAQ: INTS), and Relay Therapeutics, Inc. (NASDAQ: RLAY).
Chutes & Ladders— BMS banks on Wall Street vet for long-term strategy guidance
11 days ago
... Relay Therapeutics. Wolf will be based at Isomorphic's new location in...
Relay Therapeutics, Inc. (RLAY): Analyst Ratings Signal A 313.69% Upside Potential For Investors
11 days ago
Specializing in precision medicines, Relay Therapeutics focuses on enhancing the development of...